Literature DB >> 11641858

Osteoarthritis. How to manage pain and improve patient function.

B H McCarberg1, K A Herr.   

Abstract

Osteoarthritis (OA) typically affects persons over age 60 and is often associated with pain and disability. Weight-bearing joints are most commonly affected. The goal of treatment is to minimize pain and its impact on patient function and quality of life. Patient education, psychological support, weight control, exercise, heat/cold application, and use of assistive devices are safe nonpharmacologic approaches. Pharmacologic therapies include acetaminophen, selected NSAIDs, and other analgesics, including opioids for moderate to severe pain. Topical agents, complementary products, viscosupplementation, and surgery may be useful in an individualized treatment plan.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11641858

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  4 in total

1.  Activity limitations and participation restrictions in women with hand osteoarthritis: patients' descriptions and associations between dimensions of functioning.

Authors:  I Kjeken; H Dagfinrud; B Slatkowsky-Christensen; P Mowinckel; T Uhlig; T K Kvien; A Finset
Journal:  Ann Rheum Dis       Date:  2005-04-13       Impact factor: 19.103

2.  The effect of high resistance weight training on reported pain in older adults.

Authors:  Kathleen M Knutzen; Bethany A Pendergrast; Billie Lindsey; Lorraine R Brilla
Journal:  J Sports Sci Med       Date:  2007-12-01       Impact factor: 2.988

3.  Efficacy and safety of Biqi capsule in the treatment of knee osteoarthritis: A protocol of a randomized controlled trial.

Authors:  YaZhou Zhou; WenGang Wang; Ke Tian; Hui Huang; Mengrui Jia
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

4.  Effectiveness of two Arthritis Foundation programs: Walk With Ease, and YOU Can Break the Pain Cycle.

Authors:  Michelle Bruno; Susan Cummins; Lisha Gaudiano; Johanna Stoos; Peter Blanpied
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.